Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.
Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic, has initiated legal action, accusing its main competitor, Eli Lilly, of false advertising. The lawsuit claims Eli Lilly's promotional
Cookies on xabarchi
We use cookies to remember your language and theme, and to count how many people are reading right now — that count is anonymous, lasts only while your browser is open, and cannot be tied to you or to another visit. With your permission we also measure how the site is read: Microsoft Clarity, which records page views and on-page interactions, and our own count of returning readers. Nothing that recognises you across visits is measured until you accept.
